Literature DB >> 27741558

The Group A Streptococcus serotype M2 pilus plays a role in host cell adhesion and immune evasion.

Jia-Yun C Tsai1,2, Jacelyn M S Loh1,2, Fiona Clow1, Natalie Lorenz1, Thomas Proft1,2.   

Abstract

Group A Streptococcus (GAS), or Streptococcus pyogenes, is a human pathogen that causes diseases ranging from skin and soft tissue infections to severe invasive diseases, such as toxic shock syndrome. Each GAS strain carries a particular pilus type encoded in the variable fibronectin-binding, collagen-binding, T antigen (FCT) genomic region. Here, we describe the functional analysis of the serotype M2 pilus encoded in the FCT-6 region. We found that, in contrast to other investigated GAS pili, the ancillary pilin 1 lacks adhesive properties. Instead, the backbone pilin is important for host cell adhesion and binds several host factors, including fibronectin and fibrinogen. Using a panel of recombinant pilus proteins, GAS gene deletion mutants and Lactococcus lactis gain-of-function mutants we show that, unlike other GAS pili, the FCT-6 pilus also contributes to immune evasion. This was demonstrated by a delay in blood clotting, increased intracellular survival of the bacteria in macrophages, higher bacterial survival rates in human whole blood and greater virulence in a Galleria mellonella infection model in the presence of fully assembled FCT-6 pili.
© 2016 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27741558     DOI: 10.1111/mmi.13556

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  12 in total

1.  Incremental Contributions of FbaA and Other Impetigo-Associated Surface Proteins to Fitness and Virulence of a Classical Group A Streptococcal Skin Strain.

Authors:  Candace N Rouchon; Anhphan T Ly; John P Noto; Feng Luo; Sergio Lizano; Debra E Bessen
Journal:  Infect Immun       Date:  2017-10-18       Impact factor: 3.441

2.  PilVax: A Novel Platform for the Development of Mucosal Vaccines.

Authors:  Catherine Jia-Yun Tsai; Jacelyn M S Loh; Thomas Proft
Journal:  Methods Mol Biol       Date:  2022

3.  Identification and Characterization of Serotype-Specific Variation in Group A Streptococcus Pilus Expression.

Authors:  Gregory Calfee; Jessica L Danger; Ira Jain; Eric W Miller; Poulomee Sarkar; Brian Tjaden; Bernd Kreikemeyer; Paul Sumby
Journal:  Infect Immun       Date:  2018-01-22       Impact factor: 3.441

4.  Population and Whole Genome Sequence Based Characterization of Invasive Group A Streptococci Recovered in the United States during 2015.

Authors:  Sopio Chochua; Ben J Metcalf; Zhongya Li; Joy Rivers; Saundra Mathis; Delois Jackson; Robert E Gertz; Velusamy Srinivasan; Ruth Lynfield; Chris Van Beneden; Lesley McGee; Bernard Beall
Journal:  mBio       Date:  2017-09-19       Impact factor: 7.867

5.  Mucosal vaccination with pili from Group A Streptococcus expressed on Lactococcus lactis generates protective immune responses.

Authors:  Jacelyn M S Loh; Natalie Lorenz; Catherine J-Y Tsai; Adrina Hema J Khemlani; Thomas Proft
Journal:  Sci Rep       Date:  2017-08-03       Impact factor: 4.379

6.  Thermosensitive pilus production by FCT type 3 Streptococcus pyogenes controlled by Nra regulator translational efficiency.

Authors:  Masanobu Nakata; Tomoko Sumitomo; Nadja Patenge; Bernd Kreikemeyer; Shigetada Kawabata
Journal:  Mol Microbiol       Date:  2019-11-11       Impact factor: 3.501

Review 7.  Streptococcus pneumoniae Type 1 Pilus - A Multifunctional Tool for Optimized Host Interaction.

Authors:  Stefan Ness; Markus Hilleringmann
Journal:  Front Microbiol       Date:  2021-02-09       Impact factor: 5.640

Review 8.  Genetics, Structure, and Function of Group A Streptococcal Pili.

Authors:  Masanobu Nakata; Bernd Kreikemeyer
Journal:  Front Microbiol       Date:  2021-02-09       Impact factor: 5.640

9.  T4 Pili Promote Colonization and Immune Evasion Phenotypes of Nonencapsulated M4 Streptococcus pyogenes.

Authors:  Yi-Hsuan Chen; Shao-Hui Li; Yao-Cheng Yang; Shu-Hao Hsu; Victor Nizet; Yung-Chi Chang
Journal:  mBio       Date:  2020-07-21       Impact factor: 7.867

10.  A multivalent T-antigen-based vaccine for Group A Streptococcus.

Authors:  Jacelyn M S Loh; Tania Rivera-Hernandez; Reuben McGregor; Adrina Hema J Khemlani; Mei Lin Tay; Amanda J Cork; Jeremy M Raynes; Nicole J Moreland; Mark J Walker; Thomas Proft
Journal:  Sci Rep       Date:  2021-02-23       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.